Cipro Buyers, Generics Cos. Duel Over Actavis Ruling
Several generic-drug makers and a group of purchasers suing them over so-called pay-for-delay patent settlements related to Cipro offered dueling interpretations of the U.S. Supreme Court's recent Actavis decision Friday as...To view the full article, register now.
Already a subscriber? Click here to view full article